USAdvisors Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$217K Buy
855
+1
+0.1% +$233 0.06% 138
2026
Q1
$207K Buy
+854
New +$199K 0.07% 130
2023
Q3
Sell
-1,234
Closed -$204K 107
2023
Q2
$204K Sell
1,234
-506
-29% -$81.7K 0.1% 97
2023
Q1
$270K Buy
+1,740
New +$281K 0.13% 99
2020
Q1
Sell
-1,500
Closed -$219K 83
2019
Q4
$219K Buy
+1,500
New +$203K 0.11% 80

Other funds holding JNJ

USAdvisors Wealth Management's JNJ Position: Q2 2026 in Review

USAdvisors Wealth Management increased its Johnson & Johnson (JNJ) stake by 0.12% in Q2 2026, buying an estimated $233 and bringing the position to 855 shares worth $217K. The position accounts for 0.06% of the portfolio, ranked #138.

USAdvisors Wealth Management first reported a position in JNJ in Q4 2019 and has held it in 5 quarters since. The position peaked at $270K in Q1 2023. 2,299 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • USAdvisors Wealth Management held 855 shares of Johnson & Johnson worth $217K as of Q2 2026.
  • USAdvisors Wealth Management bought 1 Johnson & Johnson share in Q2 2026, an estimated $233.
  • Johnson & Johnson made up 0.06% of USAdvisors Wealth Management's portfolio in Q2 2026, its #138 holding.
  • USAdvisors Wealth Management first reported a position in Johnson & Johnson in Q4 2019 and has held it in 5 quarters since.
  • USAdvisors Wealth Management's Johnson & Johnson position peaked at $270K in Q1 2023.
  • 2,299 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on USAdvisors Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.